Clarivate (NYSE:CLVT) shares climb 16% - here's why. November 3, 2026 Key points. * Clarivate shares surged 16% to approximately $1.93, with trading volume below the stock's average daily volume. * Analyst sentiment remains cautious: the stock has an average "Reduce" rating and a $2.77 consensus price target after several firms cut their targets. * Clarivate beat quarterly EPS estimates, reporting $0.21 versus $0.18 expected, but revenue fell 22.7% year over year to $481.6 million; meanwhile, a director bought 250,000 shares, increasing insider ownership to 22.88%. * MarketBeat previews the top five stocks to own by December 1st. Clarivate PLC (NYSE:CLVT - Get Free Report) shot up 16% during trading on Tuesday. The company traded as high as $1.85 and last traded at $1.9250. Approximately 2,741,625 shares traded hands during trading, a decline of 54% from the average daily volume of 5,971,210 shares. The stock had previously closed at $1.66. Analysts set new price targets. Several analysts have recently commented on CLVT shares. Stifel Nicolaus decreased their price objective on shares of Clarivate from $6.00 to $5.00 and set a "buy" rating on the stock in a research report on Thursday, July 30th. Wall Street Zen lowered Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Citigroup cut their price target on Clarivate from $2.80 to $2.50 and set a "neutral" rating for the company in a research note on Thursday, July 30th. Barclays decreased their price target on Clarivate from $2.50 to $2.00 and set an "underweight" rating on the stock in a report on Thursday, July 30th. Finally, The Goldman Sachs Group lowered their price objective on Clarivate from $2.90 to $2.60 and set a "neutral" rating on the stock in a research report on Thursday, July 30th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Reduce" and an average target price of $2.77. Clarivate stock up 18.4%. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.93. The company has a fifty day moving average price of $1.81 and a 200-day moving average price of $2.22. The stock has a market capitalization of $1.26 billion, a P/E ratio of -3.78 and a beta of 1.40. Discover more MarketBeat All Access Stock Market News Stock Screener Tool Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.21 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.03. The company had revenue of $481.60 million during the quarter, compared to analyst estimates of $566.77 million. Clarivate had a positive return on equity of 9.15% and a negative net margin of 13.84%. The firm's revenue was down 22.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.18 earnings per share. As a group, research analysts forecast that Clarivate PLC will post 0.67 EPS for the current fiscal year. Insider transactions at Clarivate. In related news, Director Kenneth Cornick bought 250,000 shares of the business's stock in a transaction dated Friday, August 7th. The shares were purchased at an average price of $1.85 per share, with a total value of $462,500.00. Following the transaction, the director owned 2,000,000 shares in the company, valued at $3,700,000. This trade represents a 14.29% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 22.88% of the stock is currently owned by company insiders. Institutional trading of Clarivate. A number of institutional investors have recently bought and sold shares of CLVT. First Trust Advisors LP boosted its stake in shares of Clarivate by 10.3% during the 1st quarter. First Trust Advisors LP now owns 5,522,601 shares of the company's stock worth $13,972,000 after purchasing an additional 516,418 shares during the period. Empowered Funds LLC boosted its position in shares of Clarivate by 418.6% during the first quarter. Empowered Funds LLC now owns 2,015,829 shares of the company's stock valued at $5,100,000 after buying an additional 1,627,159 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Clarivate by 1.3% during the first quarter. Bank of New York Mellon Corp now owns 1,845,148 shares of the company's stock valued at $4,668,000 after buying an additional 24,257 shares during the last quarter. KBC Group NV bought a new position in shares of Clarivate during the first quarter valued at approximately $4,118,000. Finally, Arrowstreet Capital Limited Partnership bought a new position in shares of Clarivate during the first quarter valued at approximately $3,342,000. 85.72% of the stock is currently owned by institutional investors. Clarivate company profile. Clarivate Plc NYSE: CLVT provides analytics, data, and workflow solutions to organizations in academia, government, research, life sciences, and intellectual property. Its offerings are designed to help customers evaluate research, manage information, accelerate innovation, and support strategic decision-making. The company's products include Web of Science research databases and citation analytics, InCites research evaluation tools, Derwent innovation and patent intelligence services, and Cortellis life sciences and drug-development information. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Clarivate, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list. While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys. The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public. Continue following MarketBeat

Clarivate Plc will bring its CompuMark trademark data into Microsoft Copilot through IPOne, a connector that lets intellectual property (IP) professionals use the data inside AI-powered workflows. The company announced the move in London on November 2, 2026. IPOne lets users query and analyse trademark intelligence through natural language, purpose-built AI agents, and tools such as Copilot. Clarivate calls it the intelligence infrastructure for AI-powered IP decisions. Simon Webster, Clarivate's president of intellectual property, said: "Trusted AI starts with trusted data." Clarivate is developing IPOne with corporate IP teams at 15 Fortune 500 companies and leading law firms.

Clarivate plans Microsoft Copilot integration for trademark research. Key takeaways. * Clarivate plans to integrate CompuMark trademark data with Microsoft Copilot through its IPOne connector. * IPOne enables AI-assisted trademark research using natural-language queries and proprietary intellectual property data. * Clarivate's Microsoft Copilot integration aims to streamline legal workflows while supporting enterprise data governance. Clarivate announced plans to integrate its CompuMark trademark data with Microsoft Copilot through IPOne, a connector designed to support AI-assisted intellectual property research. The integration will allow trademark professionals to query and analyze Clarivate's proprietary data using natural language within Microsoft Copilot. IPOne is intended to connect specialized intellectual property information with AI agents and existing enterprise workflows, reducing the need to switch between research platforms. Clarivate said it is developing IPOne in collaboration with corporate intellectual property teams at 15 Fortune 500 companies and leading law firms. The announcement did not specify a general availability date or pricing for the Copilot integration. For enterprise developers, the initiative illustrates how software vendors are connecting proprietary datasets to AI assistants rather than building separate conversational interfaces. Trademark research requires accurate information about existing registrations and potential conflicts, making data quality particularly important when AI is used to support legal decisions. Organizations adopting such integrations must also consider access controls, data licensing and the reliability of AI-generated interpretations. The "RCP Channel Briefing" blog is researched, fact-checked, edited and updated by the editors of RCPmag.com, with writing assistance from AI. To submit your channel company's press release for consideration, contact Ammaarah Mohamed. Posted by Redmond Channel Partner magazine staff on November 02, 2026